[{"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-001", "question": "A 45-year-old man with a history of bipolar disorder presents with acute agitation, auditory hallucinations, and disorganized thinking after discontinuing his lithium therapy 2 weeks ago. He has a serum creatinine of 1.8 mg/dL and reports recent use of ibuprofen for headaches. Which of the following is the most appropriate initial management?", "options": ["Administer haloperidol intramuscularly", "Restart lithium at half the previous dose", "Initiate valproic acid orally", "Perform hemodialysis", "Administer lorazepam intravenously"], "answer": "D", "answer_index": 3, "explanation": "Hemodialysis is indicated due to lithium toxicity exacerbated by NSAID-induced renal impairment, leading to elevated lithium levels causing neurotoxicity. Haloperidol and lorazepam address symptoms but not the underlying toxicity, while restarting lithium or starting valproic acid risks worsening the condition without clearance.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: M (Multiple answers defensible). The stem describes a 45-year-old man with bipolar disorder who discontinued lithium 2 weeks ago and now presents with acute agitation, auditory hallucinations, and disorganized thinking. He has renal impairment (creatinine 1.8 mg/dL) and recent ibuprofen use. The key discriminating findings are recent lithium discontinuation, current psychotic symptoms, and renal impairment. The most likely clinical problem is an acute manic episode with psychotic features, not lithium toxicity. Therefore, initial management should target acute psychosis and agitation. Both haloperidol (A) and lorazepam (E) are appropriate and defensible; no single best answer is clearly superior. Hemodialysis (D) is unsupported because lithium toxicity is unlikely after 2 weeks off therapy and no lithium level is provided. The keyed answer is incorrect and not defensible. The item is logically invalid because multiple options are equally plausible (M). Medically, the rationale is inaccurate: hemodialysis is not indicated without confirmed lithium toxicity, and the scenario reflects mania, not toxicity. Minor medical nuance: renal impairment and NSAID use are red herrings. Minimal fix: Change the key to A (haloperidol) and revise rationale to state that acute mania with psychosis requires antipsychotic therapy; hemodialysis is not indicated.\",\n\"medical_accuracy_score\":   \t\"1\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). The stem describes a 45-year-old man with bipolar disorder who discontinued lithium 2 weeks ago and now presents with acute agitation, auditory hallucinations, and disorganized thinking. He has renal impairment (creatinine 1.8 mg/dL) and recent ibuprofen use. The key discriminating findings are recent lithium discontinuation, current psychotic symptoms, and renal impairment. The most likely clinical problem is an acute manic episode with psychotic features, not lithium toxicity. Therefore, initial management should target acute psychosis and agitation. Both haloperidol (A) and lorazepam (E) are appropriate and defensible; no single best answer is clearly superior. Hemodialysis (D) is unsupported because lithium toxicity is unlikely after 2 weeks off therapy and no lithium level is provided. The keyed answer is incorrect and not defensible. The item is logically invalid because multiple options are equally plausible (M). Medically, the rationale is inaccurate: hemodialysis is not indicated without confirmed lithium toxicity, and the scenario reflects mania, not toxicity. Minor medical nuance: renal impairment and NSAID use are red herrings. Minimal fix: Change the key to A (haloperidol) and revise rationale to state that acute mania with psychosis requires antipsychotic therapy; hemodialysis is not indicated.", "medical_accuracy_score": 1, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 1}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-002", "question": "A 32-year-old woman with schizophrenia on clozapine develops fever, tachycardia, and muscle rigidity. Laboratory findings include elevated creatine kinase and leukocytosis. Which rare adverse effect is most likely responsible, and what is the next step in management?", "options": ["Agranulocytosis; discontinue clozapine and start G-CSF", "Neuroleptic malignant syndrome; administer dantrolene and bromocriptine", "Serotonin syndrome; give cyproheptadine", "Catatonia; initiate electroconvulsive therapy", "Myocarditis; perform echocardiography and stop clozapine"], "answer": "B", "answer_index": 1, "explanation": "Neuroleptic malignant syndrome is the diagnosis, requiring immediate supportive care with dantrolene for rigidity and bromocriptine for dopamine agonism. Agranulocytosis presents with infection without rigidity, serotonin syndrome lacks CK elevation typically, catatonia is behavioral, and myocarditis involves cardiac symptoms primarily.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Keyed answer is correct best answer. The stem’s classic tetrad—fever, tachycardia, muscle rigidity, and marked CK elevation in a clozapine-treated patient—points unequivocally to neuroleptic malignant syndrome (NMS). Leukocytosis further supports this diagnosis. Option B correctly identifies NMS and appropriate pharmacologic therapy (dantrolene for rigidity/hyperthermia, bromocriptine as dopamine agonist). Alternative options are appropriately excluded: agranulocytosis lacks rigidity/CK elevation; serotonin syndrome requires serotonergic agents and presents with hyperreflexia/clonus rather than severe rigidity; catatonia shows less pronounced autonomic instability and CK rise; myocarditis would feature cardiac-predominant symptoms. No internal contradictions exist, and options are readily discriminable. Medical accuracy is sound, though the management description is slightly oversimplified: the immediate next step is discontinuing clozapine and providing supportive care, which option B omits. This is a minor board-style simplification. Minimal fix: revise option B to ‘Neuroleptic malignant syndrome; discontinue clozapine and administer dantrolene and bromocriptine.’\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Keyed answer is correct best answer. The stem’s classic tetrad—fever, tachycardia, muscle rigidity, and marked CK elevation in a clozapine-treated patient—points unequivocally to neuroleptic malignant syndrome (NMS). Leukocytosis further supports this diagnosis. Option B correctly identifies NMS and appropriate pharmacologic therapy (dantrolene for rigidity/hyperthermia, bromocriptine as dopamine agonist). Alternative options are appropriately excluded: agranulocytosis lacks rigidity/CK elevation; serotonin syndrome requires serotonergic agents and presents with hyperreflexia/clonus rather than severe rigidity; catatonia shows less pronounced autonomic instability and CK rise; myocarditis would feature cardiac-predominant symptoms. No internal contradictions exist, and options are readily discriminable. Medical accuracy is sound, though the management description is slightly oversimplified: the immediate next step is discontinuing clozapine and providing supportive care, which option B omits. This is a minor board-style simplification. Minimal fix: revise option B to ‘Neuroleptic malignant syndrome; discontinue clozapine and administer dantrolene and bromocriptine.’", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-003", "question": "A 65-year-old man undergoes laparoscopic cholecystectomy for acute cholecystitis. Intraoperatively, there is significant bleeding from the cystic artery that is difficult to control. Postoperative imaging reveals a pseudoaneurysm. What is the most appropriate intervention?", "options": ["Endoscopic retrograde cholangiopancreatography with stenting", "Angiographic embolization", "Surgical re-exploration with ligation", "Percutaneous transhepatic cholangiography", "Observation with serial imaging"], "answer": "B", "answer_index": 1, "explanation": "Angiographic embolization is preferred for postoperative pseudoaneurysm to minimize invasiveness and control bleeding effectively. Surgical re-exploration carries higher morbidity, ERCP addresses biliary issues not vascular, PTC is for drainage, and observation risks rupture.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: The keyed answer B is the correct best choice. Key stem clues: postoperative pseudoaneurysm following difficult-to-control cystic artery bleeding during laparoscopic cholecystectomy. This is a vascular complication requiring hemorrhage control. Main logical issue: None. The stem clearly defines a vascular problem, and options are appropriately distinct—only angiographic embolization directly addresses pseudoaneurysm management. ERCP/PTC target biliary pathology (leaks or obstruction), observation is unsafe given rupture risk, and surgical re-exploration is more invasive than necessary. Main medical accuracy issue: None. Angiographic embolization is the established first-line, minimally invasive treatment for postoperative hepatic artery pseudoaneurysms, with high success rates and lower morbidity than surgery. The rationale correctly identifies that surgical re-exploration is reserved for embolization failure or hemodynamic instability. The scenario is realistic and aligns with current interventional radiology and surgical society guidelines. Minimal fix: No changes required; the item is board-ready as written.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: The keyed answer B is the correct best choice. Key stem clues: postoperative pseudoaneurysm following difficult-to-control cystic artery bleeding during laparoscopic cholecystectomy. This is a vascular complication requiring hemorrhage control. Main logical issue: None. The stem clearly defines a vascular problem, and options are appropriately distinct—only angiographic embolization directly addresses pseudoaneurysm management. ERCP/PTC target biliary pathology (leaks or obstruction), observation is unsafe given rupture risk, and surgical re-exploration is more invasive than necessary. Main medical accuracy issue: None. Angiographic embolization is the established first-line, minimally invasive treatment for postoperative hepatic artery pseudoaneurysms, with high success rates and lower morbidity than surgery. The rationale correctly identifies that surgical re-exploration is reserved for embolization failure or hemodynamic instability. The scenario is realistic and aligns with current interventional radiology and surgical society guidelines. Minimal fix: No changes required; the item is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-004", "question": "A 50-year-old woman with Crohn's disease presents with an enterocutaneous fistula after ileocolic resection. She is hemodynamically stable but has high-output fistula drainage. Which management strategy is most effective for promoting spontaneous closure?", "options": ["Total parenteral nutrition and somatostatin analog", "Immediate surgical closure with bowel resection", "Antibiotic therapy with abscess drainage", "Hyperbaric oxygen therapy", "Fibrin glue injection into the fistula tract"], "answer": "A", "answer_index": 0, "explanation": "TPN and somatostatin analogs reduce gastrointestinal secretions and promote fistula healing in high-output cases. Surgical closure is reserved for failures, antibiotics address infection not closure, hyperbaric oxygen lacks evidence, and fibrin glue is for low-output fistulas.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": V (Valid). Verdict: Keyed answer is correct best choice. The stem identifies a hemodynamically stable patient with a high-output enterocutaneous fistula following Crohn's surgery, asking for management to promote spontaneous closure. Key discriminating features are 'high-output' and 'stable,' which direct toward conservative measures rather than immediate surgery. The standard approach is bowel rest via TPN to reduce secretions and somatostatin analogs to further decrease output, creating conditions favorable for spontaneous closure over 4-6 weeks. Option A aligns with this algorithm. Alternative analysis: B (immediate surgery) is incorrect as first-line for high-output fistulas; C addresses infection but not closure mechanics; D lacks evidence; E is indicated for low-output fistulas, not high-output. No internal contradictions exist, and all options are mutually exclusive and testable. Medical accuracy is sound: TPN+somatostatin is consensus initial management for high-output fistulas per major surgical/gastroenterology guidelines, though evidence for somatostatin improving closure rates (vs. just output reduction) has nuances. Minor limitation: 'High-output' is not quantified (e.g., >500 mL/day), but the term is standard and sufficient for discrimination. Minimal fix: Add specific drainage volume (e.g., 'draining 800 mL/day') to remove any ambiguity for borderline cases.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": V (Valid). Verdict: Keyed answer is correct best choice. The stem identifies a hemodynamically stable patient with a high-output enterocutaneous fistula following Crohn's surgery, asking for management to promote spontaneous closure. Key discriminating features are 'high-output' and 'stable,' which direct toward conservative measures rather than immediate surgery. The standard approach is bowel rest via TPN to reduce secretions and somatostatin analogs to further decrease output, creating conditions favorable for spontaneous closure over 4-6 weeks. Option A aligns with this algorithm. Alternative analysis: B (immediate surgery) is incorrect as first-line for high-output fistulas; C addresses infection but not closure mechanics; D lacks evidence; E is indicated for low-output fistulas, not high-output. No internal contradictions exist, and all options are mutually exclusive and testable. Medical accuracy is sound: TPN+somatostatin is consensus initial management for high-output fistulas per major surgical/gastroenterology guidelines, though evidence for somatostatin improving closure rates (vs. just output reduction) has nuances. Minor limitation: 'High-output' is not quantified (e.g., >500 mL/day), but the term is standard and sufficient for discrimination. Minimal fix: Add specific drainage volume (e.g., 'draining 800 mL/day') to remove any ambiguity for borderline cases.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-005", "question": "A 60-year-old man with diabetes presents with sudden painless vision loss in the right eye. Fundoscopy shows macular edema and neovascularization at the disc. Optical coherence tomography confirms vitreomacular traction. What is the most appropriate initial treatment?", "options": ["Intravitreal anti-VEGF injection", "Panretinal photocoagulation", "Pars plana vitrectomy", "Intravitreal corticosteroid", "Observation with follow-up"], "answer": "C", "answer_index": 2, "explanation": "Pars plana vitrectomy addresses vitreomacular traction in proliferative diabetic retinopathy with macular involvement, relieving traction and allowing further therapy. Anti-VEGF and laser treat neovascularization but not traction, corticosteroids risk complications, and observation may worsen vision.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). Verdict: The keyed answer (C – pars plana vitrectomy) is the correct best choice. The stem provides sudden painless vision loss, macular edema, neovascularization at the disc (high‑risk proliferative diabetic retinopathy), and OCT‑confirmed vitreomacular traction. The presence of traction indicates a mechanical component contributing to the macular edema; relieving it with vitrectomy is the most direct initial step and also permits endolaser photocoagulation during surgery. Anti‑VEGF and panretinal photocoagulation treat neovascularization but do not address traction, intravitreal steroids carry higher complication risks, and observation would allow progression. No internal contradictions exist, and the options are sufficiently distinct to permit a single best answer. Medical accuracy: Current guidelines endorse vitrectomy for diabetic macular edema with vitreomacular traction, especially when high‑risk proliferative disease is present; the explanation correctly distinguishes traction‑relieving therapy from neovascular‑targeted treatments. No major inaccuracies. Minimal fix: add “no prior panretinal photocoagulation” to the stem to clarify that vitrectomy is the first intervention, though the item is already defensible without this addition.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). Verdict: The keyed answer (C – pars plana vitrectomy) is the correct best choice. The stem provides sudden painless vision loss, macular edema, neovascularization at the disc (high‑risk proliferative diabetic retinopathy), and OCT‑confirmed vitreomacular traction. The presence of traction indicates a mechanical component contributing to the macular edema; relieving it with vitrectomy is the most direct initial step and also permits endolaser photocoagulation during surgery. Anti‑VEGF and panretinal photocoagulation treat neovascularization but do not address traction, intravitreal steroids carry higher complication risks, and observation would allow progression. No internal contradictions exist, and the options are sufficiently distinct to permit a single best answer. Medical accuracy: Current guidelines endorse vitrectomy for diabetic macular edema with vitreomacular traction, especially when high‑risk proliferative disease is present; the explanation correctly distinguishes traction‑relieving therapy from neovascular‑targeted treatments. No major inaccuracies. Minimal fix: add “no prior panretinal photocoagulation” to the stem to clarify that vitrectomy is the first intervention, though the item is already defensible without this addition.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-006", "question": "A 25-year-old athlete sustains a tibial plateau fracture with associated meniscal tear and ACL disruption. Intraoperative findings include a depressed lateral plateau fragment. What is the optimal surgical approach to restore joint congruity?", "options": ["External fixation with delayed internal fixation", "Arthroscopic-assisted reduction and internal fixation", "Open reduction with bone grafting and buttress plating", "Total knee arthroplasty", "Nonoperative management with bracing"], "answer": "C", "answer_index": 2, "explanation": "Open reduction with bone grafting and buttress plating restores articular surface in complex tibial plateau fractures with depression. Arthroscopic assistance is for simpler cases, external fixation is temporary, arthroplasty is for older patients, and nonoperative risks malunion.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. The vignette presents a 25‑year‑old athlete with a depressed lateral tibial plateau fracture, meniscal tear, and ACL disruption, asking for the optimal surgical approach to restore joint congruity. The critical discriminating features are the young age, high functional demand, and an intra‑articular depression that requires anatomic reduction and rigid support. Current orthopedic consensus dictates open reduction and internal fixation (ORIF) with bone grafting (or substitute) and buttress plating to elevate and stabilize the fragment. Option C (open reduction with bone grafting and buttress plating) directly addresses these requirements. Option B (arthroscopic‑assisted reduction) is less appropriate for a depressed fragment because it cannot reliably provide the necessary elevation and buttress support; it is reserved for non‑depressed or minimally displaced patterns. Options A (external fixation) and E (nonoperative) fail to restore articular congruity, and D (total knee arthroplasty) is contraindicated in a young athlete. No internal contradictions or missing details preclude a single best answer. The keyed answer aligns with AO/OTA and OTA guidelines for Schatzker II–III fractures. No safety concerns. Minimal fix: none required.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The vignette presents a 25‑year‑old athlete with a depressed lateral tibial plateau fracture, meniscal tear, and ACL disruption, asking for the optimal surgical approach to restore joint congruity. The critical discriminating features are the young age, high functional demand, and an intra‑articular depression that requires anatomic reduction and rigid support. Current orthopedic consensus dictates open reduction and internal fixation (ORIF) with bone grafting (or substitute) and buttress plating to elevate and stabilize the fragment. Option C (open reduction with bone grafting and buttress plating) directly addresses these requirements. Option B (arthroscopic‑assisted reduction) is less appropriate for a depressed fragment because it cannot reliably provide the necessary elevation and buttress support; it is reserved for non‑depressed or minimally displaced patterns. Options A (external fixation) and E (nonoperative) fail to restore articular congruity, and D (total knee arthroplasty) is contraindicated in a young athlete. No internal contradictions or missing details preclude a single best answer. The keyed answer aligns with AO/OTA and OTA guidelines for Schatzker II–III fractures. No safety concerns. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-007", "question": "A 55-year-old woman with multiple sclerosis presents with progressive spastic paraparesis and urinary incontinence. MRI shows a syrinx from C4 to T2 without Chiari malformation. What is the most likely underlying mechanism, and appropriate management?", "options": ["Post-traumatic syrinx; syringoperitoneal shunting", "Idiopathic syringomyelia; conservative monitoring", "Tumoral syrinx; biopsy and resection", "Inflammatory syrinx due to MS; high-dose steroids", "Arachnoiditis-related; laminectomy with adhesiolysis"], "answer": "A", "answer_index": 0, "explanation": "Post-traumatic syrinx in MS context likely from prior demyelination scars disrupting CSF flow, managed with shunting to prevent progression. Idiopathic lacks MS history, tumoral requires mass evidence, steroids treat acute flares not syrinx, adhesiolysis is for specific scarring.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: U (Underspecified) with secondary M (Multiple answers defensible). Verdict: Keyed answer not uniquely defensible due to non-standard terminology. The stem presents progressive syrinx in MS without Chiari; key clues are MS diagnosis, syrinx location, and progressive myelopathy. Standard pathophysiology attributes MS-related syrinx to inflammatory arachnoiditis disrupting CSF flow, not 'post-traumatic' mechanisms. Option A's mechanism is non-standard and medically inaccurate, while its management (shunting) is appropriate for progressive symptomatic syrinx. Option D correctly identifies inflammatory mechanism but incorrectly pairs it with high-dose steroids, which treat MS flares, not syrinx. Option B ignores the MS association. The item requires accepting the rationale's idiosyncratic definition of 'post-traumatic' to select A, making it underspecified. This creates a near-tie between A and D along mechanism-management dimensions, satisfying M. Main medical inaccuracy: mislabeling MS-associated syrinx as 'post-traumatic' misrepresents pathophysiology. Minimal fix: Revise option A to 'MS-related inflammatory arachnoiditis; syringoperitoneal shunting' to align mechanism with standard nomenclature while preserving the correct management.\",\"medical_accuracy_score\":2,\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified) with secondary M (Multiple answers defensible). Verdict: Keyed answer not uniquely defensible due to non-standard terminology. The stem presents progressive syrinx in MS without Chiari; key clues are MS diagnosis, syrinx location, and progressive myelopathy. Standard pathophysiology attributes MS-related syrinx to inflammatory arachnoiditis disrupting CSF flow, not 'post-traumatic' mechanisms. Option A's mechanism is non-standard and medically inaccurate, while its management (shunting) is appropriate for progressive symptomatic syrinx. Option D correctly identifies inflammatory mechanism but incorrectly pairs it with high-dose steroids, which treat MS flares, not syrinx. Option B ignores the MS association. The item requires accepting the rationale's idiosyncratic definition of 'post-traumatic' to select A, making it underspecified. This creates a near-tie between A and D along mechanism-management dimensions, satisfying M. Main medical inaccuracy: mislabeling MS-associated syrinx as 'post-traumatic' misrepresents pathophysiology. Minimal fix: Revise option A to 'MS-related inflammatory arachnoiditis; syringoperitoneal shunting' to align mechanism with standard nomenclature while preserving the correct management.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-008", "question": "A 40-year-old man with epilepsy on carbamazepine develops diplopia, ataxia, and nystagmus. Serum levels are therapeutic, but free fraction is elevated. What is the most likely cause, and adjustment needed?", "options": ["Hyponatremia; restrict fluids", "Drug interaction with protein binding; reduce dose", "Autoinduction; increase dose", "Hepatic failure; switch to alternative", "Renal impairment; hemodialysis"], "answer": "B", "answer_index": 1, "explanation": "Elevated free carbamazepine due to hypoalbuminemia or displacement increases toxicity despite therapeutic total levels, requiring dose reduction. Hyponatremia causes different symptoms, autoinduction lowers levels, hepatic failure elevates total levels, renal issues don't directly affect binding.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: therapeutic total carbamazepine level, elevated free fraction, and classic neurotoxicity (diplopia, ataxia, nystagmus) indicate increased pharmacologically active drug due to protein-binding displacement or hypoalbuminemia. Answer B correctly identifies a drug–protein-binding interaction as the cause and dose reduction as the appropriate adjustment. Alternative options are clearly inferior: hyponatremia (A) produces different symptoms; autoinduction (C) would lower total levels; hepatic failure (D) would raise total levels and is not suggested; renal impairment (E) does not affect binding. No internal contradictions; only B is defensible. Minor limitation: the stem does not specify the interacting drug, but the concept remains testable. Medical accuracy: aligns with current pharmacology—carbamazepine is highly protein bound, and increased free fraction can cause toxicity despite therapeutic total levels; dose reduction is the standard management. No major inaccuracies. Minimal fix: add a phrase such as 'while on concurrent valproic acid' to explicitly cue protein-binding displacement.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: therapeutic total carbamazepine level, elevated free fraction, and classic neurotoxicity (diplopia, ataxia, nystagmus) indicate increased pharmacologically active drug due to protein-binding displacement or hypoalbuminemia. Answer B correctly identifies a drug–protein-binding interaction as the cause and dose reduction as the appropriate adjustment. Alternative options are clearly inferior: hyponatremia (A) produces different symptoms; autoinduction (C) would lower total levels; hepatic failure (D) would raise total levels and is not suggested; renal impairment (E) does not affect binding. No internal contradictions; only B is defensible. Minor limitation: the stem does not specify the interacting drug, but the concept remains testable. Medical accuracy: aligns with current pharmacology—carbamazepine is highly protein bound, and increased free fraction can cause toxicity despite therapeutic total levels; dose reduction is the standard management. No major inaccuracies. Minimal fix: add a phrase such as 'while on concurrent valproic acid' to explicitly cue protein-binding displacement.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-009", "question": "A 35-year-old woman presents with erythematous plaques on the trunk and positive Darier's sign. Biopsy shows mast cell infiltration. Systemic symptoms include flushing and diarrhea. What is the most appropriate long-term management?", "options": ["Oral cromolyn sodium", "Imatinib therapy", "Omalizumab injections", "Bone marrow transplantation", "Interferon-alpha"], "answer": "A", "answer_index": 0, "explanation": "Oral cromolyn stabilizes mast cells in cutaneous mastocytosis with systemic features, reducing mediator release. Imatinib is for KIT mutations not present here, omalizumab for allergic components, transplantation for aggressive forms, interferon for indolent systemic mastocytosis.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (logically sound). Verdict: Correct best answer. The stem’s key discriminating findings—erythematous plaques with positive Darier’s sign, dermal mast cell infiltrate, and systemic mediator symptoms (flushing, diarrhea)—establish systemic mastocytosis with cutaneous involvement. The question asks for the most appropriate long-term management. Among the options, oral cromolyn sodium is the only first-line, disease-targeted therapy that reduces mast cell mediator release and is indicated for chronic skin and GI symptoms in indolent systemic mastocytosis. Imatinib is reserved for specific KIT mutations (not mentioned and typically absent in D816V-positive disease), omalizumab is not standard for mastocytosis, and both interferon-α and bone marrow transplantation are reserved for refractory or aggressive disease, which is not suggested by the vignette. No internal contradictions exist, and the options are mutually exclusive enough to permit a single best choice. Medical accuracy: the keyed answer aligns with current guidelines (e.g., WHO, UpToDate) that recommend cromolyn for mediator-related symptoms in indolent systemic mastocytosis. Minor nuance: the stem does not explicitly state the KIT mutation status, which could cause confusion about imatinib eligibility; however, the absence of aggressive features already directs away from imatinib. Minimal fix: add a clause to the stem stating ‘No KIT D816V mutation is detected’ to explicitly rule out imatinib and reinforce the choice of cromolyn.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (logically sound). Verdict: Correct best answer. The stem’s key discriminating findings—erythematous plaques with positive Darier’s sign, dermal mast cell infiltrate, and systemic mediator symptoms (flushing, diarrhea)—establish systemic mastocytosis with cutaneous involvement. The question asks for the most appropriate long-term management. Among the options, oral cromolyn sodium is the only first-line, disease-targeted therapy that reduces mast cell mediator release and is indicated for chronic skin and GI symptoms in indolent systemic mastocytosis. Imatinib is reserved for specific KIT mutations (not mentioned and typically absent in D816V-positive disease), omalizumab is not standard for mastocytosis, and both interferon-α and bone marrow transplantation are reserved for refractory or aggressive disease, which is not suggested by the vignette. No internal contradictions exist, and the options are mutually exclusive enough to permit a single best choice. Medical accuracy: the keyed answer aligns with current guidelines (e.g., WHO, UpToDate) that recommend cromolyn for mediator-related symptoms in indolent systemic mastocytosis. Minor nuance: the stem does not explicitly state the KIT mutation status, which could cause confusion about imatinib eligibility; however, the absence of aggressive features already directs away from imatinib. Minimal fix: add a clause to the stem stating ‘No KIT D816V mutation is detected’ to explicitly rule out imatinib and reinforce the choice of cromolyn.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-010", "question": "A 55-year-old man with prostate cancer on androgen deprivation therapy develops urinary retention. Cystoscopy reveals bladder neck contracture. What is the most effective definitive treatment?", "options": ["Transurethral incision of the bladder neck", "Suprapubic catheter placement", "Alpha-blocker therapy", "Intravesical botulinum toxin injection", "Urethral dilation with sounds"], "answer": "A", "answer_index": 0, "explanation": "Transurethral incision relieves bladder neck contracture post-ADT, providing durable relief. Suprapubic catheter is palliative, alpha-blockers ineffective for scarring, botulinum for detrusor issues, dilation temporary and recurrent.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem establishes bladder neck contracture (BNC) in a patient on ADT, asking for the most effective definitive treatment. Key discriminating clues are the cystoscopic diagnosis of fibrotic contracture and the qualifier \\\"definitive.\\\" Transurethral incision of the bladder neck (TUIBN) directly incises fibrotic tissue, providing durable relief with low recurrence, making it the standard definitive management. The keyed answer A is therefore correct. Alternative analysis: B (suprapubic catheter) is palliative, not definitive; C (alpha-blockers) relax smooth muscle but cannot resolve fibrosis; D (intravesical botulinum) targets detrusor overactivity, not BNC; E (urethral dilation) offers only temporary relief with high recurrence rates. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is sound: TUIBN is the established definitive treatment for BNC, while other options are inappropriate for definitive management. The scenario is clinically plausible, though BNC is more commonly post-prostatectomy/radiation than ADT alone. No critical details are missing for answer selection. Minimal fix: None required; item is board-ready as written.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem establishes bladder neck contracture (BNC) in a patient on ADT, asking for the most effective definitive treatment. Key discriminating clues are the cystoscopic diagnosis of fibrotic contracture and the qualifier \"definitive.\" Transurethral incision of the bladder neck (TUIBN) directly incises fibrotic tissue, providing durable relief with low recurrence, making it the standard definitive management. The keyed answer A is therefore correct. Alternative analysis: B (suprapubic catheter) is palliative, not definitive; C (alpha-blockers) relax smooth muscle but cannot resolve fibrosis; D (intravesical botulinum) targets detrusor overactivity, not BNC; E (urethral dilation) offers only temporary relief with high recurrence rates. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is sound: TUIBN is the established definitive treatment for BNC, while other options are inappropriate for definitive management. The scenario is clinically plausible, though BNC is more commonly post-prostatectomy/radiation than ADT alone. No critical details are missing for answer selection. Minimal fix: None required; item is board-ready as written.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-011", "question": "A 28-year-old pregnant woman at 32 weeks gestation with major depressive disorder relapses after stopping sertraline. She has suicidal ideation. What is the most appropriate pharmacologic intervention?", "options": ["Restart sertraline at previous dose", "Initiate electroconvulsive therapy", "Start bupropion extended-release", "Prescribe mirtazapine", "Use transcranial magnetic stimulation"], "answer": "B", "answer_index": 1, "explanation": "ECT is safe and effective for severe depression in pregnancy with suicidality, avoiding fetal medication exposure. Sertraline risks neonatal adaptation syndrome, bupropion seizure risk, mirtazapine sedation, TMS less evidence in acute suicidality.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: C (Contradiction). Verdict: The item is internally inconsistent; it asks for a pharmacologic intervention but includes ECT and TMS, which are not pharmacologic. The keyed answer B is not a pharmacologic intervention, making the question unsolvable as written. Key stem clues: 32‑week pregnant woman, major depressive disorder relapse after sertraline discontinuation, active suicidal ideation. Main logical issue: The stem’s wording (‘pharmacologic intervention’) conflicts with the answer choices; a non‑pharmacologic option cannot be the correct answer to a pharmacologic question. Main medical accuracy issue: The answer explanation correctly states that ECT is safe and effective in pregnancy for severe depression with suicidality, and that sertraline carries a neonatal adaptation risk, bupropion a seizure risk, mirtazapine sedation, and TMS has limited evidence for acute suicidality. However, the explanation does not address that sertraline remains a reasonable pharmacologic option in this scenario. Minimal fix: Change the stem to ask for the ‘most appropriate treatment’ (removing ‘pharmacologic’) or replace options B and E with pharmacologic alternatives.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). Verdict: The item is internally inconsistent; it asks for a pharmacologic intervention but includes ECT and TMS, which are not pharmacologic. The keyed answer B is not a pharmacologic intervention, making the question unsolvable as written. Key stem clues: 32‑week pregnant woman, major depressive disorder relapse after sertraline discontinuation, active suicidal ideation. Main logical issue: The stem’s wording (‘pharmacologic intervention’) conflicts with the answer choices; a non‑pharmacologic option cannot be the correct answer to a pharmacologic question. Main medical accuracy issue: The answer explanation correctly states that ECT is safe and effective in pregnancy for severe depression with suicidality, and that sertraline carries a neonatal adaptation risk, bupropion a seizure risk, mirtazapine sedation, and TMS has limited evidence for acute suicidality. However, the explanation does not address that sertraline remains a reasonable pharmacologic option in this scenario. Minimal fix: Change the stem to ask for the ‘most appropriate treatment’ (removing ‘pharmacologic’) or replace options B and E with pharmacologic alternatives.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-012", "question": "A 60-year-old man with alcohol use disorder presents with confabulation, ophthalmoplegia, and ataxia. MRI shows mamillary body atrophy. What is the underlying deficiency, and specific treatment?", "options": ["Vitamin B12; intramuscular cyanocobalamin", "Thiamine; intravenous thiamine", "Folate; oral folic acid", "Vitamin E; alpha-tocopherol", "Magnesium; intravenous magnesium sulfate"], "answer": "B", "answer_index": 1, "explanation": "Thiamine deficiency causes Wernicke-Korsakoff syndrome, treated urgently with IV thiamine to prevent irreversible damage. B12 deficiency causes subacute combined degeneration, folate anemia, vitamin E ataxia without confabulation, magnesium tremors not ophthalmoplegia.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of confabulation, ophthalmoplegia, ataxia, alcohol use disorder, and mamillary body atrophy on MRI is pathognomonic for thiamine deficiency causing Wernicke-Korsakoff syndrome. Keyed answer B (thiamine; IV thiamine) is uniquely defensible as the only option addressing this specific deficiency and its urgent treatment. Distractors are well-differentiated: A (B12) causes subacute combined degeneration without ophthalmoplegia; C (folate) causes megaloblastic anemia; D (vitamin E) causes spinocerebellar ataxia without confabulation; E (magnesium) causes tremors/seizures but not this triad. No internal contradictions, missing critical details, or option overlap. Medical content is accurate, current, and aligns with emergency neurology guidelines recommending immediate IV thiamine before glucose. The item tests a high-yield, board-relevant association with precise discriminators. No fix needed.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of confabulation, ophthalmoplegia, ataxia, alcohol use disorder, and mamillary body atrophy on MRI is pathognomonic for thiamine deficiency causing Wernicke-Korsakoff syndrome. Keyed answer B (thiamine; IV thiamine) is uniquely defensible as the only option addressing this specific deficiency and its urgent treatment. Distractors are well-differentiated: A (B12) causes subacute combined degeneration without ophthalmoplegia; C (folate) causes megaloblastic anemia; D (vitamin E) causes spinocerebellar ataxia without confabulation; E (magnesium) causes tremors/seizures but not this triad. No internal contradictions, missing critical details, or option overlap. Medical content is accurate, current, and aligns with emergency neurology guidelines recommending immediate IV thiamine before glucose. The item tests a high-yield, board-relevant association with precise discriminators. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-013", "question": "A 42-year-old woman undergoes Whipple procedure for pancreatic adenocarcinoma. Postoperatively, she develops delayed gastric emptying with high nasogastric output. What is the most effective prokinetic agent?", "options": ["Metoclopramide intravenously", "Erythromycin orally", "Domperidone orally", "Prucalopride", "Octreotide subcutaneously"], "answer": "B", "answer_index": 1, "explanation": "Erythromycin acts as a motilin agonist to enhance gastric motility in post-Whipple delayed emptying. Metoclopramide risks tardive dyskinesia, domperidone cardiac issues, prucalopride for colon, octreotide inhibits motility.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: post‑Whipple delayed gastric emptying with high nasogastric output → need for prokinetic. Most effective agent is erythromycin (motilin agonist). Keyed answer B (erythromycin orally) aligns with this principle; oral route is less ideal than IV but the agent itself remains the best choice among options. Alternatives: metoclopramide (less effective, tardive dyskinesia risk), domperidone (QT risk), prucalopride (colon‑specific), octreotide (inhibits motility). No internal contradictions; a single best answer is defensible. Main logical issue: none. Main medical accuracy issue: route specification (oral) is non‑standard; IV erythromycin is preferred for DGE after Whipple, but the question’s focus is on the agent, not the route, so the item remains clinically accurate. The question mirrors board‑style emphasis on recognizing erythromycin as the preferred prokinetic in this setting; the oral route is a minor technicality that does not alter the core teaching point. No other option offers a comparable mechanism or efficacy. Minimal fix: change option B to \\\"Erythromycin intravenously\\\" to reflect usual practice and avoid route ambiguity.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: post‑Whipple delayed gastric emptying with high nasogastric output → need for prokinetic. Most effective agent is erythromycin (motilin agonist). Keyed answer B (erythromycin orally) aligns with this principle; oral route is less ideal than IV but the agent itself remains the best choice among options. Alternatives: metoclopramide (less effective, tardive dyskinesia risk), domperidone (QT risk), prucalopride (colon‑specific), octreotide (inhibits motility). No internal contradictions; a single best answer is defensible. Main logical issue: none. Main medical accuracy issue: route specification (oral) is non‑standard; IV erythromycin is preferred for DGE after Whipple, but the question’s focus is on the agent, not the route, so the item remains clinically accurate. The question mirrors board‑style emphasis on recognizing erythromycin as the preferred prokinetic in this setting; the oral route is a minor technicality that does not alter the core teaching point. No other option offers a comparable mechanism or efficacy. Minimal fix: change option B to \"Erythromycin intravenously\" to reflect usual practice and avoid route ambiguity.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-014", "question": "A 70-year-old man with diverticulitis undergoes Hartmann's procedure. Six months later, he presents for reversal but has severe cardiac comorbidity. What is the safest reversal technique?", "options": ["Laparoscopic colostomy reversal with anastomosis", "Open reversal with protective ileostomy", "Endoscopic stenting of the rectal stump", "Percutaneous endoscopic colostomy", "Continued observation"], "answer": "A", "answer_index": 0, "explanation": "Laparoscopic approach minimizes morbidity in high-risk patients for Hartmann's reversal. Open with ileostomy adds procedures, stenting not for reversal, PEC for constipation, observation avoids surgery but maintains stoma.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues—severe cardiac comorbidity and appropriate 6-month interval—drive selection of the least invasive surgical approach. Laparoscopic reversal (A) offers reduced morbidity versus open (B) and avoids additional procedures like protective ileostomy. Options C and D are not reversal techniques; E represents non-operative management and does not answer the question as framed. No internal contradictions exist. Main logical issue: None; options permit clear discrimination. Main medical accuracy issue: Slight underspecification regarding precise cardiac status and surgical optimization, but the general principle favoring minimally invasive methods in high-risk patients is correctly applied and aligns with current consensus. Minimal fix: Add 'deemed a surgical candidate' to the stem and rephrase option E as 'Defer reversal due to prohibitive cardiac risk' to clarify the non-operative alternative.\",\"medical_accuracy_score\":  \"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues—severe cardiac comorbidity and appropriate 6-month interval—drive selection of the least invasive surgical approach. Laparoscopic reversal (A) offers reduced morbidity versus open (B) and avoids additional procedures like protective ileostomy. Options C and D are not reversal techniques; E represents non-operative management and does not answer the question as framed. No internal contradictions exist. Main logical issue: None; options permit clear discrimination. Main medical accuracy issue: Slight underspecification regarding precise cardiac status and surgical optimization, but the general principle favoring minimally invasive methods in high-risk patients is correctly applied and aligns with current consensus. Minimal fix: Add 'deemed a surgical candidate' to the stem and rephrase option E as 'Defer reversal due to prohibitive cardiac risk' to clarify the non-operative alternative.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-015", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops corneal melt and peripheral ulcerative keratitis. What is the most appropriate immunosuppressive therapy adjustment?", "options": ["Add infliximab infusion", "Switch to rituximab", "Initiate cyclophosphamide", "Topical cyclosporine", "Systemic corticosteroids with azathioprine"], "answer": "C", "answer_index": 2, "explanation": "Cyclophosphamide is used for severe ocular manifestations in rheumatoid vasculitis like corneal melt. Infliximab for joints, rituximab B-cell depletion insufficient alone, topical for surface, steroids with azathioprine less potent for melt.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem’s key discriminating findings are a patient with rheumatoid arthritis on methotrexate who now has corneal melt and peripheral ulcerative keratitis (PUK), a severe ocular manifestation of rheumatoid vasculitis. This scenario requires potent systemic immunosuppression. Cyclophosphamide is widely recognized as a first‑line agent for necrotizing scleritis and corneal melt in RA because of its strong immunosuppressive effect and ability to halt vasculitic progression. The other options are less appropriate: infliximab lacks strong evidence for ocular disease, rituximab is effective but often used as second‑line or in combination, topical cyclosporine is insufficient for deep stromal melt, and steroids plus azathioprine are less potent than cyclophosphamide for this indication. No internal contradictions exist, and the options allow clear discrimination. Medical accuracy is high; the only minor nuance is that rituximab is also a valid alternative, but cyclophosphamide remains a board‑level best answer. Minimal fix: add \\\"with systemic vasculitis\\\" or \\\"severe\\\" to the stem to explicitly justify the choice of cyclophosphamide.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem’s key discriminating findings are a patient with rheumatoid arthritis on methotrexate who now has corneal melt and peripheral ulcerative keratitis (PUK), a severe ocular manifestation of rheumatoid vasculitis. This scenario requires potent systemic immunosuppression. Cyclophosphamide is widely recognized as a first‑line agent for necrotizing scleritis and corneal melt in RA because of its strong immunosuppressive effect and ability to halt vasculitic progression. The other options are less appropriate: infliximab lacks strong evidence for ocular disease, rituximab is effective but often used as second‑line or in combination, topical cyclosporine is insufficient for deep stromal melt, and steroids plus azathioprine are less potent than cyclophosphamide for this indication. No internal contradictions exist, and the options allow clear discrimination. Medical accuracy is high; the only minor nuance is that rituximab is also a valid alternative, but cyclophosphamide remains a board‑level best answer. Minimal fix: add \"with systemic vasculitis\" or \"severe\" to the stem to explicitly justify the choice of cyclophosphamide.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-016", "question": "A 35-year-old man sustains a humeral shaft fracture with radial nerve palsy. Exploration shows nerve entrapment in the fracture site. What is the optimal management of the nerve injury?", "options": ["Immediate nerve grafting", "Neurolysis and fracture fixation", "Nerve transfer from triceps branch", "Tendon transfer for wrist extension", "Observation with serial EMG"], "answer": "B", "answer_index": 1, "explanation": "Neurolysis frees the entrapped radial nerve during fracture fixation, allowing potential recovery. Grafting for transection, transfer for irreparable, tendon for chronic, observation misses surgical window.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The stem provides a clear clinical scenario: a 35-year-old man with humeral shaft fracture, radial nerve palsy, and confirmed nerve entrapment on exploration. This specific finding drives a unique management pathway. Option B (neurolysis and fracture fixation) is the definitive treatment for acute entrapment, addressing both the nerve compression and fracture stability. The rationale correctly distinguishes alternative approaches: immediate grafting (A) is inappropriate without transection; nerve transfer (C) and tendon transfer (D) are salvage procedures for irreparable or chronic injuries; observation (E) is contraindicated when entrapment is confirmed. No logical issues exist: the stem contains sufficient detail, options are distinct, and the key matches the single best answer. Medical accuracy is exemplary: this aligns with AO/ASIF principles and hand surgery consensus that acute radial nerve entrapment at a fracture site requires prompt neurolysis during fixation. The item is clinically realistic and tests a high-yield decision point. Minimal fix: none required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem provides a clear clinical scenario: a 35-year-old man with humeral shaft fracture, radial nerve palsy, and confirmed nerve entrapment on exploration. This specific finding drives a unique management pathway. Option B (neurolysis and fracture fixation) is the definitive treatment for acute entrapment, addressing both the nerve compression and fracture stability. The rationale correctly distinguishes alternative approaches: immediate grafting (A) is inappropriate without transection; nerve transfer (C) and tendon transfer (D) are salvage procedures for irreparable or chronic injuries; observation (E) is contraindicated when entrapment is confirmed. No logical issues exist: the stem contains sufficient detail, options are distinct, and the key matches the single best answer. Medical accuracy is exemplary: this aligns with AO/ASIF principles and hand surgery consensus that acute radial nerve entrapment at a fracture site requires prompt neurolysis during fixation. The item is clinically realistic and tests a high-yield decision point. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-017", "question": "A 65-year-old man with Parkinson's disease develops impulse control disorder on pramipexole. He also has motor fluctuations. What is the most appropriate medication adjustment?", "options": ["Switch to rotigotine patch", "Add entacapone", "Initiate deep brain stimulation evaluation", "Start apomorphine subcutaneous", "Convert to levodopa-benserazide"], "answer": "D", "answer_index": 3, "explanation": "Apomorphine provides rapid relief for fluctuations and may reduce dopamine agonist dose, mitigating ICD. Rotigotine similar risk, entacapone extends levodopa, DBS for advanced, levodopa increases dyskinesia risk.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (U secondary). Verdict: Miskeyed. Key clues: ICD on pramipexole + motor fluctuations in 65-year-old. The stem fails to specify whether pramipexole will be tapered/discontinued—the essential first step for ICD. This critical omission makes the item underspecified and yields multiple defensible options: B (entacapone) helps fluctuations if pramipexole is tapered; C (DBS) could be considered for refractory motor complications. The keyed answer D (apomorphine) is medically inappropriate: as a dopamine agonist, it carries ICD risk and does not reduce pramipexole dose. Its rescue role for OFF periods does not address the root cause of ICD. Medical accuracy: The rationale contains a major error by suggesting apomorphine mitigates ICD, misrepresenting standard management and potentially misleading learners about a serious neuropsychiatric complication. This reflects outdated or incorrect understanding of ICD pathophysiology. Score 2. Minimal fix: Add 'taper pramipexole' to stem and change key to B, or replace D with 'taper pramipexole and add entacapone.'\",\"medical_accuracy_score\":                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \"2\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (U secondary). Verdict: Miskeyed. Key clues: ICD on pramipexole + motor fluctuations in 65-year-old. The stem fails to specify whether pramipexole will be tapered/discontinued—the essential first step for ICD. This critical omission makes the item underspecified and yields multiple defensible options: B (entacapone) helps fluctuations if pramipexole is tapered; C (DBS) could be considered for refractory motor complications. The keyed answer D (apomorphine) is medically inappropriate: as a dopamine agonist, it carries ICD risk and does not reduce pramipexole dose. Its rescue role for OFF periods does not address the root cause of ICD. Medical accuracy: The rationale contains a major error by suggesting apomorphine mitigates ICD, misrepresenting standard management and potentially misleading learners about a serious neuropsychiatric complication. This reflects outdated or incorrect understanding of ICD pathophysiology. Score 2. Minimal fix: Add 'taper pramipexole' to stem and change key to B, or replace D with 'taper pramipexole and add entacapone.'", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-018", "question": "A 50-year-old woman with migraine presents with hemiplegic episodes and family history of similar symptoms. Genetic testing reveals CACNA1A mutation. What is the most effective prophylactic treatment?", "options": ["Verapamil extended-release", "Topiramate", "Propranolol", "Amitriptyline", "Valproate"], "answer": "A", "answer_index": 0, "explanation": "Verapamil is preferred for familial hemiplegic migraine due to calcium channel involvement. Topiramate and valproate for common migraine, propranolol beta-blockade, amitriptyline for tension overlap.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem’s key clues—hemiplegic episodes, family history, and a CACNA1A mutation—establish a diagnosis of familial hemiplegic migraine type 1, a calcium‑channelopathy. Verapamil, a calcium‑channel blocker, directly targets the pathophysiology and is widely regarded in current neurology practice as first‑line prophylaxis for this disorder. Alternative options (topiramate, valproate, propranolol, amitriptyline) are effective for common migraine but lack specific targeting of the CACNA1A defect, making them less optimal for this specific scenario. No internal contradictions exist, and the options allow clear discrimination. Medical accuracy: Verapamil’s preference for FHM is supported by expert consensus and case series; the explanation oversimplifies the role of other agents but does not introduce error. Minor nuance: evidence is limited, and the term ‘most effective’ could be misinterpreted; changing the stem to ‘most appropriate initial prophylactic treatment based on the channelopathy’ would remove ambiguity. Overall, the item is logically sound and clinically acceptable.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem’s key clues—hemiplegic episodes, family history, and a CACNA1A mutation—establish a diagnosis of familial hemiplegic migraine type 1, a calcium‑channelopathy. Verapamil, a calcium‑channel blocker, directly targets the pathophysiology and is widely regarded in current neurology practice as first‑line prophylaxis for this disorder. Alternative options (topiramate, valproate, propranolol, amitriptyline) are effective for common migraine but lack specific targeting of the CACNA1A defect, making them less optimal for this specific scenario. No internal contradictions exist, and the options allow clear discrimination. Medical accuracy: Verapamil’s preference for FHM is supported by expert consensus and case series; the explanation oversimplifies the role of other agents but does not introduce error. Minor nuance: evidence is limited, and the term ‘most effective’ could be misinterpreted; changing the stem to ‘most appropriate initial prophylactic treatment based on the channelopathy’ would remove ambiguity. Overall, the item is logically sound and clinically acceptable.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-019", "question": "A 40-year-old man with HIV on antiretroviral therapy develops violaceous plaques on the legs. Biopsy shows spindle cells and HHV-8 positivity. What is the most appropriate systemic therapy?", "options": ["Liposomal doxorubicin", "Interferon-alpha", "Thalidomide", "Sirolimus", "Rituximab"], "answer": "D", "answer_index": 3, "explanation": "Sirolimus inhibits mTOR in AIDS-related Kaposi sarcoma, reducing progression in immunocompromised patients. Doxorubicin for advanced, interferon immunomodulation, thalidomide anti-angiogenic but toxic, rituximab for lymphoid.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: The item is miskeyed; liposomal doxorubicin is the standard systemic therapy for advanced AIDS-related Kaposi sarcoma, not sirolimus. Key stem clues—HIV infection, violaceous plaques, spindle cells, HHV-8 positivity—establish a diagnosis of AIDS-related KS. While sirolimus (mTOR inhibitor) has demonstrated efficacy in transplant-associated KS, liposomal doxorubicin remains the first-line systemic chemotherapy for advanced AIDS-KS per NCCN and IDSA guidelines. The question is slightly underspecified regarding disease extent, but board convention assumes systemic therapy is indicated when specifically requested. Alternative options are appropriately nonstandard: interferon-alpha is outdated, thalidomide has toxicity concerns, and rituximab is irrelevant. The primary logical flaw is key mismatch; the item would be valid if correctly keyed. Medical accuracy is compromised by presenting sirolimus as the 'most appropriate' therapy, which misrepresents current standard of care and could mislead learners. Minimal fix: Change correct answer to A (Liposomal doxorubicin) and revise rationale to state it is the established first-line systemic therapy for advanced AIDS-KS, with sirolimus reserved for transplant settings or refractory cases.\",\"medical_accuracy_score\":   \"2\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: The item is miskeyed; liposomal doxorubicin is the standard systemic therapy for advanced AIDS-related Kaposi sarcoma, not sirolimus. Key stem clues—HIV infection, violaceous plaques, spindle cells, HHV-8 positivity—establish a diagnosis of AIDS-related KS. While sirolimus (mTOR inhibitor) has demonstrated efficacy in transplant-associated KS, liposomal doxorubicin remains the first-line systemic chemotherapy for advanced AIDS-KS per NCCN and IDSA guidelines. The question is slightly underspecified regarding disease extent, but board convention assumes systemic therapy is indicated when specifically requested. Alternative options are appropriately nonstandard: interferon-alpha is outdated, thalidomide has toxicity concerns, and rituximab is irrelevant. The primary logical flaw is key mismatch; the item would be valid if correctly keyed. Medical accuracy is compromised by presenting sirolimus as the 'most appropriate' therapy, which misrepresents current standard of care and could mislead learners. Minimal fix: Change correct answer to A (Liposomal doxorubicin) and revise rationale to state it is the established first-line systemic therapy for advanced AIDS-KS, with sirolimus reserved for transplant settings or refractory cases.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-020", "question": "A 60-year-old man with chronic kidney disease stage 4 presents with hematuria and flank pain. Imaging shows a Bosniak IV cyst with enhancing nodule. What is the most appropriate management?", "options": ["Partial nephrectomy", "Active surveillance", "Radiofrequency ablation", "Percutaneous biopsy", "Radical nephrectomy"], "answer": "A", "answer_index": 0, "explanation": "Partial nephrectomy preserves renal function in CKD while addressing malignant potential of Bosniak IV cyst. Surveillance for lower categories, ablation for small tumors, biopsy diagnostic not therapeutic, radical sacrifices nephrons.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key discriminating clues: Bosniak IV cyst (≥90% malignancy risk, mandating definitive treatment) and CKD stage 4 (eGFR 15–29 mL/min) establishing critical need for nephron preservation. Partial nephrectomy is the guideline-concordant, nephron-sparing oncologic intervention for complex cystic lesions amenable to resection. Alternative assessment: Active surveillance is contraindicated for Bosniak IV; radiofrequency ablation lacks evidence for cystic lesions; percutaneous biopsy has high false-negative rates and is non-therapeutic; radical nephrectomy unnecessarily sacrifices nephrons in a patient with limited renal reserve. No internal contradictions. While tumor size/location are not specified, standard exam convention assumes technical feasibility when not stated; the CKD context makes partial nephrectomy the unequivocal 'most appropriate' choice. Medical accuracy is gold-standard: perfectly aligns with AUA and EAU guidelines prioritizing nephron-sparing surgery for complex cystic renal masses in patients with pre-existing renal insufficiency. Minimal fix: None required; item is board-exam ready.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key discriminating clues: Bosniak IV cyst (≥90% malignancy risk, mandating definitive treatment) and CKD stage 4 (eGFR 15–29 mL/min) establishing critical need for nephron preservation. Partial nephrectomy is the guideline-concordant, nephron-sparing oncologic intervention for complex cystic lesions amenable to resection. Alternative assessment: Active surveillance is contraindicated for Bosniak IV; radiofrequency ablation lacks evidence for cystic lesions; percutaneous biopsy has high false-negative rates and is non-therapeutic; radical nephrectomy unnecessarily sacrifices nephrons in a patient with limited renal reserve. No internal contradictions. While tumor size/location are not specified, standard exam convention assumes technical feasibility when not stated; the CKD context makes partial nephrectomy the unequivocal 'most appropriate' choice. Medical accuracy is gold-standard: perfectly aligns with AUA and EAU guidelines prioritizing nephron-sparing surgery for complex cystic renal masses in patients with pre-existing renal insufficiency. Minimal fix: None required; item is board-exam ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]